A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)

Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has...

Descripción completa

Detalles Bibliográficos
Autores principales: Eris, Erdem, Erdogan, Gurkan, Perente, Irfan, Demir, Gokhan, Kepez Yildiz, Burcin, Aygit, Ebru Demet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643104/
https://www.ncbi.nlm.nih.gov/pubmed/29098101
http://dx.doi.org/10.1155/2017/6369085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643104/
https://www.ncbi.nlm.nih.gov/pubmed/29098101
http://dx.doi.org/10.1155/2017/6369085

Ejemplares similares